Last reviewed · How we verify

Fluzone HD Vaccine

David H. Canaday · FDA-approved active Small molecule ✓ Verified May 2026 Quality 2/100

Fluzone HD Vaccine is a Small molecule drug developed by David H. Canaday. It is currently FDA-approved.

The Fluzone HD Vaccine is a vaccine component that induces an immune response, classified as a biological vaccine. It is used to prevent influenza and has been studied in various clinical trials, including those involving individuals with immune defects and healthy volunteers.

At a glance

Generic nameFluzone HD Vaccine
SponsorDavid H. Canaday
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fluzone HD Vaccine

What is Fluzone HD Vaccine?

Fluzone HD Vaccine is a Small molecule drug developed by David H. Canaday.

Who makes Fluzone HD Vaccine?

Fluzone HD Vaccine is developed and marketed by David H. Canaday (see full David H. Canaday pipeline at /company/david-h-canaday).

What development phase is Fluzone HD Vaccine in?

Fluzone HD Vaccine is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing